ClinicalTrialsFinder

PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM) Clinical Trials in La Jolla, California

1 recruitingLa Jolla, California

Showing 1–1 of 1 trials

Recruiting
Phase 1

A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)

PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Rocket Pharmaceuticals Inc.9 enrolled3 locationsNCT05885412